![Max M. Søgaard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Max M. Søgaard
Director Técnico/Científico/I+D en
EXPRES2ION BIOTECH HOLDING AB
.
Perfil
Max M.
Søgaard currently works at Expres2ion Biotech Holding AB, as Chief Scientific Officer from 2025.
Dr. Søgaard received his graduate degree from the University of Aarhus and doctorate degree from University College London.
Cargos activos de Max M. Søgaard
| Empresas | Cargo | Inicio |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Director Técnico/Científico/I+D | 01/01/2020 |
Formación de Max M. Søgaard.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
8
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
University of Aarhus
 University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Expres2ion Biotech Holding AB
 Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
- Bolsa de valores
- Insiders
- Max M. Søgaard
